Yaron D Barac Selected Research

Yaron D Barac Research Topics

10	Heart Failure 03/2022 - 07/2011
5	Myocardial Infarction 01/2021 - 08/2015
2	Cardiomyopathies (Cardiomyopathy) 10/2022 - 12/2019
2	Systolic Heart Failure 03/2020 - 05/2018
2	Fibrosis (Cirrhosis) 08/2015 - 07/2011
2	Hypertrophy 07/2011 - 10/2005
1	Cardiac Arrhythmias (Arrythmia) 10/2022
1	Ventricular Fibrillation 10/2022
1	Congenitally Corrected Transposition of the Great Arteries 03/2022
1	Coronary Disease (Coronary Heart Disease) 02/2022
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2022
1	Endocarditis 06/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Obesity 01/2021
1	Hemolysis 01/2020
1	Brain Death (Brain Dead) 01/2020
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2019
1	Muscular Atrophy (Muscle Atrophy) 12/2019
1	Right Ventricular Dysfunction 12/2019
1	Hemorrhage 05/2019
1	Heart Neoplasms 01/2019
1	Diabetes Mellitus 01/2019
1	Pulmonary Hypertension 01/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2019
1	Lung Diseases (Lung Disease) 01/2019
1	Thrombosis (Thrombus) 05/2018
1	Acute Coronary Syndrome 02/2018
1	Left Ventricular Dysfunction 02/2018
1	Cardiomegaly (Heart Hypertrophy) 07/2017
1	Ventricular Remodeling 08/2015
1	Ischemia 08/2015
1	Cicatrix (Scar) 08/2015
1	Pheochromocytoma 01/2012
1	Hypoxia (Hypoxemia) 04/2005

3	Proteins (Proteins, Gene)FDA Link 12/2019 - 04/2005
3	rasagiline (Azilect)FDA Link 08/2015 - 07/2011
2	UbiquitinIBA 12/2019 - 07/2017
2	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2019 - 07/2017
2	Connexin 43 (Connexin43)IBA 10/2005 - 04/2005
1	Anti-Arrhythmia AgentsIBA 10/2022
1	Dihydrotachysterol (AT 10)IBA 06/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Eukaryotic Initiation Factor-4EIBA 12/2019
1	prothrombin complex concentrates (PPSB)IBA 05/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	TicagrelorIBA 09/2017
1	Prasugrel Hydrochloride FDA Link 09/2017
1	Pharmaceutical PreparationsIBA 08/2015
1	CollagenIBA 08/2015
1	Mitogen-Activated Protein Kinase 3IBA 01/2012
1	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2011
1	Type C PhospholipasesIBA 10/2005
1	Messenger RNA (mRNA)IBA 10/2005
1	Inositol (Myoinositol)IBA 10/2005
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 10/2005
1	Inositol 1,4,5-TrisphosphateIBA 10/2005
1	1- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dioneIBA 10/2005
1	fas Receptor (CD95 Antigen)IBA 10/2005
1	GenisteinIBA 10/2005
1	Glycogen Synthase Kinase 3 betaIBA 10/2005
1	xestospongin CIBA 10/2005
1	Atrial Natriuretic Factor (ANF)IBA 10/2005
1	Protein Isoforms (Isoforms)IBA 04/2005

11	Heart-Assist Devices 10/2022 - 05/2018
3	Heart Transplantation (Grafting, Heart) 03/2022 - 12/2019
3	Percutaneous Coronary Intervention 02/2022 - 08/2015
3	Therapeutics 01/2021 - 07/2011
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2021 - 09/2017
1	Transplantation 10/2022
1	Electric Countershock (Cardioversion) 10/2022
1	Prostheses and Implants (Prosthesis) 06/2021
1	Liver Transplantation 12/2019
1	Autologous Transplantation 01/2019
1	Lung Transplantation 01/2019
1	Artificial Respiration (Mechanical Ventilation) 02/2018
1	Thrombolytic Therapy 08/2015
1	Electrodes (Electrode) 04/2005